Cust Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cust study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cust Study Today - Breaking & Trending Today

GSK : Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial - Form 6-K -December 18, 2023 at 06:38 am EST

A1192x

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER. ....

United Kingdom General , United Kingdom , Treasure Island , United States , City Of , James Dodwell , Tim Foley , Camilla Campbell , Jeff Mclaughlin , Mick Readey , Dan Smith , Hesham Abdullah , Josh Williams , Lyndsay Meyer , Steph Mountifield , Kathleen Quinn , Nick Stone , European Society Of Gynaecological Oncology , Commission File Number , Securities Exchange , European Network Of Gynaecological Oncological Trial , Kantar Health , Anaptysbio Inc , Tesaro Inc , International Research On Cancer , File Number ,

GSK : Phase III RUBY trial of Jemperli (dostarlimab) plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer - Form 6-K -October 30, 2023 at 07:13 am EDT

A6268r

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER. ....

United Kingdom , United States , City Of , Treasure Island , United Kingdom General , Nick Stone , Tim Foley , Camilla Campbell , Mick Readey , James Dodwell , Steph Mountifield , Kathleen Quinn , Jeff Mclaughlin , Lyndsay Meyer , Dan Smith , Josh Williams , Hesham Abdullah , European Union , Securities Exchange , Anaptysbio Inc , Tesaro Inc , Kantar Health , International Research On Cancer , Commission File Number , File Number , West Road ,

GSK : European Medicines Agency validates marketing authorisation application for Jemperli (dostarlimab) plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer - Form 6-K

European Medicines Agency validates marketing authorisation application for Jemperli plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer

. | April 25, 2023 ....

United Kingdom General , United Kingdom , United States , City Of , Treasure Island , Hesham Abdullah , Steph Mountifield , Dan Smith , Kathleen Quinn , Tim Foley , Jeff Mclaughlin , Camilla Campbell , James Dodwell , Mick Readey , Nick Stone , Josh Williams , Lyndsay Meyer , Committee For Medicinal Products Human , Tesaro Inc , European Commission , Anaptysbio Inc , International Research On Cancer , European Society For Medical Oncology Virtual Plenary , Society Of Gynecologic Oncology Annual Meeting , Kantar Health , Global Head Of Oncology Development ,

AnaptysBio- and GSK-partnered immuno-oncology agent

Results published in The New England Journal of Medicine and presented simultaneously at ESMO Virtual Plenary and SGO Annual Meeting72% and 36% reduction. ....

United States , Nick Montemarano , Daniel Faga , Exchange Commission , Tesaro Inc , European Society For Medical Oncology , International Research On Cancer , Strategic Communications , Anaptysbio Inc , Kantar Health , Society Of Gynecologic Oncology , Thenew England Journal , European Society , Medical Oncology , Virtual Plenary , Gynecologic Oncology , Annual Meeting , Exclusive License Agreement , Sagard Healthcare Royalty Partners , Response Evaluation Criteria , Solid Tumors , Prescribing Information , Private Securities Litigation Reform Act , Investor Relations , International Research , Global Cancer ,

US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer

/PRNewswire/ GSK plc (LSE/NYSE: GSK) today reports that the US Food and Drug Administration (FDA) granted full approval for Jemperli (dostarlimab-gxly) for. ....

City Of , United Kingdom , United States , United Kingdom General , Hesham Abdullah , Kathleen Quinn , Dan Smith , Camilla Campbell , Josh Williams , Jeff Mclaughlin , Mick Readey , Lyndsay Meyer , Tim Foley , James Dodwell , Steph Mountifield , Nick Stone , Company Annual Report On Form , Anaptysbio Inc , Kantar Health , Tesaro Inc , Global Head Of Oncology Development , Drug Administration , International Research On Cancer , Senior Vice President , Global Head , Oncology Development ,